Journal
EXPERIMENTAL CELL RESEARCH
Volume 256, Issue 1, Pages 42-49Publisher
ELSEVIER INC
DOI: 10.1006/excr.2000.4838
Keywords
-
Categories
Funding
- NCI NIH HHS [CA69008, R01 CA069008, CA67818] Funding Source: Medline
- Wellcome Trust [073915] Funding Source: Medline
Ask authors/readers for more resources
Studies performed over the past five years have demonstrated that there are two major cell-intrinsic pathways for inducing apoptosis, one that begins with ligation of cell surface death receptors and another that involves mitochondrial release of cytochrome c, Several reports have suggested that anticancer drugs kill susceptible cells by inducing expression of death receptor Ligands, especially Fas ligand (FasL), Other reports have indicated that chemotherapeutic agents trigger apoptosis by inducing release of cytochrome c from mitochondria, In this review, we describe the two prototypic death pathways, indicate experimental approaches for distinguishing whether chemotherapeutic agents trigger one pathway or the other, summarize current understanding of the role of the two pathways in chemotherapy-induced apoptosis, and discuss the implications of these studies for mechanisms of resistance to chemotherapeutic agents. (C) 2000 Academic Press.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available